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Ischemic heart disease is the main cause of death in western countries and its burden is increasing worldwide. It typically involves
irreversible degeneration and loss of myocardial tissue leading to poor prognosis and fatal outcome. Autologous cells with the
potential to regenerate damaged heart tissue would be an ideal source for cell therapeutic approaches. Here, we compared different
methods of conditional culture for increasing the yield and cardiogenic potential of murine skeletal muscle-derived stem cells. A
subpopulation of nonadherent cells was isolated from skeletal muscle by preplating and applying cell culture conditions differing
in support of cluster formation. In contrast to static culture conditions, dynamic culture with or without previous hanging drop
preculture led to significantly increased cluster diameters and the expression of cardiac specific markers on the protein and mRNA
level. Whole-cell patch-clamp studies revealed similarities to pacemaker action potentials and responsiveness to cardiac specific
pharmacological stimuli.This data indicates that skeletalmuscle-derived stem cells are capable of adopting enhanced cardiacmuscle
cell-like properties by applying specific culture conditions. Choosing this route for the establishment of a sustainable, autologous
source of cells for cardiac therapies holds the potential of being clinically more acceptable than transgenic manipulation of cells.
1. Introduction
Ischemic heart disease is the most common cause of death
worldwide [1] and is characterized by degeneration of heart
muscle tissue as a consequence of cell death resulting from
shortage of oxygen and nutritional supply. Typically, this will
result in cardiac insufficiency and ultimately heart failure,
causing substantial socioeconomic burden, most prominent
in developed countries, but increasingly throughout the
world. The human left ventricle contains approximately 2 to
4 × 109 cardiomyocytes (CMs), of which as much as 25% can
be lost in a single nonfatal event of myocardial infarction
(MI) [2]. Since the adult mammalian myocardium has only
very limited potential to regenerate [3], research on cardiac
cell therapy aims at developing methods to repair damaged
heart tissue by transplantation of therapeutically effective
cells [4, 5].
Various cell types have been tested for efficacy in cardiac
cell therapy in animal models and early clinical settings.
Since the most obvious choice of cells, functional CMs,
are not available in relevant numbers due to their limited
proliferation potential in vitro, alternative cell populations,
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mostly stem or progenitor cells, have been investigated. Early
studies concentrated on bone marrow-derived cells, due to
their relative ease of acquisition from bone marrow aspirates
and established regenerative potential for hematopoiesis and
angiogenesis [6]. General safety and moderate therapeutic
efficacy of these cells for treatment of acute cardiac infarction
have been shown in a meta-analysis of clinical trials [7].
Recently, promising results from clinical studies using cardiac
stem cells derived from patient myocardial tissue have been
published [8], but the underlying biological mechanisms
remain unresolved [9].
Another autologous cell source which has been used
in the context of cardiac cell therapy is skeletal muscle
progenitor cells, which are recruited from satellite cells in
response to muscle injury in situ and proliferate as skeletal
myoblasts (MBs) in vitro [10]. Here, despite initially promis-
ing results in animal models [11, 12] and clinical trials [13,
14], safety issues became apparent after arrhythmias had
been observed in patients receiving MBs after myocardial
infarction [13, 15], most likely due to electrophysiological
isolation of transplanted cells [16, 17]. Consequently, when
considering MBs as an option for cardiac cell therapy,
prior modification of cells is advisable, as shown recently
by our group using a nontransgenic approach [18] or by
transplantation of transgenic MBs expressing cardiac gap
junction proteins [19].
A variety of publications have reported that skeletal
muscle additionally harbors a subpopulation of multipotent
stem cells, which have been termedmuscle-derived stem cells
(MDSCs) and are subject to controversial discussion [20–
23]. To utilize the full potential of MDSCs as a source of
autologous cells for cardiac cell therapy, further clarification
of their cellular identity, differentiation potential, functional
properties, and therapeutic efficacy is required. During
the isolation of MDSCs from muscle tissue a consistently
reported characteristic feature, often used for separation from
MBs and fibroblasts [18], is a propensity for nonadherence to
cell culture plastic surfaces and the formation of cell clusters.
Our aim was to exploit this feature by supporting
nonadherence and cluster formation in early isolations of
MDSCs via the application of specific culture conditions.
By observing cell morphology, together with expression and
functional electrophysiological studies, we could confirm an
improved cardiogenic potential of these MDSCs in response
to dynamic support culture compared to standard culture in
vitro.
2. Materials and Methods
2.1. Tissue Processing and Cell Isolation. Cells were isolated
from skeletal muscles of forelimbs and hindlimbs of neona-
tal C57BL/6 mice as previously described [18, 24]. Briefly,
muscle tissue was minced and freed from connective tissue
residue by enzymatic digestion in phosphate buffer saline
(PBS; Invitrogen, Karlsruhe, Germany), containing 0.2%
collagenase type IV and 2.4 IU/mL dispase (Invitrogen) and
3mM calcium chloride (Sigma-Aldrich, Munich, Germany).
Primary cell isolates were filtered using a 70𝜇m cell strainer
(BD Biosciences, Heidelberg, Germany) and cultured in
DMEM/F12 medium with 5% fetal bovine serum, 1% ITS-X,
1% Penicillin/Streptomycin, 0.5 𝜇g/mL Fungizone (all Invit-
rogen, Karlsruhe, Germany), 10 ng/mL recombinant human
basic fibroblast growth factor, and 10 ng/mL recombinant
human epidermal growth factor (both PeproTech, Hamburg,
Germany). These cells were subjected to serial preplating
steps 2 h (pP1), 26 h (pP2), and 74 h (pP3) after isolation
in 10 cm cell culture dishes (Falcon, BD, Heidelberg, Ger-
many). After each preplating step only nonadherent cells
were passaged, while adherent cells were discarded. After
pP3, nonadherent cells were defined as day 0 cells (ISH0)
and cultured (105 cells/cm2) using three different cell culture
conditions: I (incubator), referring to the incubation of cells
applying static conditions in a standard cell culture incubator
at 37∘C and 5% CO
2
; S (shaker), referring to incubation on
a horizontal rocking platform at 50 rpm; H (hanging drop),
referring to initial incubation for 48 h in hanging drops (6
× 104 cells/20𝜇L drop) at 37∘C and 5% CO
2
, followed by S
culture conditions.
At days 4, 8, and 12, nonadherent cells were collected,
counted, and passaged. Populations of nonadherent cells were
termed according to the collection day and the condition
applied, that is, H12: hanging drop condition at day 12. Cluster
diameters were measured from microscopic images (2.5x
magnification, Axiovert 25, Zeiss, Oberkochen, Germany). A
minimum of 3 images from samples (ISH0, I12, S12, and H12)
of each isolation (𝑛 = 5) were analyzed using AxioVision 4.5
software (Zeiss). Cell numbers were assessed from samples
acquired during passaging. Samples were incubated with
Accutase (Invitrogen) for 15 minutes at 37∘C to dissociate
clusters. Cells were counted using a Neubauer hemocytome-
ter (Marienfeld, Lauda-Ko¨nigshofen, Germany). MBs [18]
and embryonic stem cell (ESC) derived CMs [25] were used
as controls for immunocytochemistry and quantitative real-
time PCR (qPCR).
2.2. Immunocytochemistry. For immunocytochemical stain-
ing, either intact or Accutase dissociated clusters were
centrifuged (500 g, 10 minutes) onto fibronectin coated
(2.5 𝜇g/mL; Sigma-Aldrich, Taufkirchen, Germany) cover-
slips and further incubated for 72 h before analysis. The
samples were fixed with 4% paraformaldehyde, permeabi-
lized with 0.25% Triton X-100/0.5M NH
4
Cl, and blocked
with 5% goat serum (all Sigma-Aldrich) in PBS (Invitrogen).
Samples were stained with 4,6-diamidino-2-phenylindole
(DAP; Invitrogen). Primary and secondary antibodies (see
Table S1 in the Supplementary Material available online at
http://dx.doi.org/10.1155/2015/247091) were diluted in PBS
with 1% bovine serum albumin (BSA, Invitrogen). Fluores-
cence microscopy was performed using a Ti-U microscope
and NIS Elements BR 3.10 software (both Nikon, Du¨sseldorf,
Germany). Ratios of cells positive formarker expression were
assessed by analyzing 5 fields of vision (20xmagnification) for
3 biological replicates (i.e., a total of >500 cells were analyzed
per marker and sample). Specificity of staining was tested by
appropriate controls (Figures S3 to S7).
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2.3. FlowCytometry. For flow cytometric analyses of intracel-
lular markers, single cells from Accutase dissociated clusters
were fixed and permeabilizedwithCytofix/Cytoperm solution
(BD). PEB (PBS with 0.5% BSA and 2mM ethylenedi-
aminetetraacetic acid, EDTA, Sigma-Aldrich) was used for
dilution of antibodies, washing, and incubation. Table S1 lists
detailed information about antibodies used. Measurements
were performed on a FACSCalibur flow cytometer with
CellQuest Pro 6 software (both BD).
2.4. Quantitative Real-Time PCR. After a final static incuba-
tion for 72 h, a minimum of 5 × 105 cells from all conditions
were used for total RNA extraction using the Nucleospin
RNA XS kit (Macherey Nagel, Du¨ren, Germany), followed by
reverse transcription, using the High Capacity cDNA reverse
transcription kit and DNase I treatment (both Invitrogen).
SYBRGreenPowerMix, 10mMoligonucleotide primers (both
Invitrogen), and 10 ng cDNA per reaction were used for
quantification of gene expression on a StepOne Plus real-
time PCR system (Applied Biosystems, ABI, Darmstadt,
Germany). Data analysis was performed using StepOne 2.2
software (ABI). See Table S2 for primer sequences.
2.5. Patch-ClampAnalysis. Electrophysiological properties of
MDSCs were assessed using whole-cell patch-clamping [26].
Cells from dissociated clusters were plated on fibronectin
coated coverslips as described for immunocytochemistry.
Pipettes (3–5MΩ resistance when filled with standard intra-
cellular solution, Table S3A) were made from thin walled
borosilicate glass capillaries tubes (World Precision Instru-
ments WPI) on a Zeitz DMZ Universal Puller (DMZ).
All recordings were performed one or two days after cell
plating, using an EPC 9 amplifier with Pulse software (HEKA
Instruments, Lambrecht, Germany), applying continuous
perfusion with buffer (extracellular solution, Table S3B) The
bath temperature was held constant at 37∘C. After establish-
ment of the gigaohmic seal, membrane capacitance 𝐶
𝑚
and
series resistance 𝑅series were compensated to minimize the
capacitive transient. Only cells showing stable values were
included in the analysis. APs were recorded in current-clamp
mode and funny current (𝐼
𝑓
) in voltage clamp mode. For
𝐼
𝑓
recording, hyperpolarizing steps from a holding potential
of −40mV to the range of −150 to −100mV in 10mV-steps
were applied. Data were digitized at 10 kHz, filtered at 1 kHz,
and stored on hard disk. Beating frequency was measured
as the number of APs per minute over the duration of 5
minutes. For indicatedmeasurements, 0.5mMCdCl
2
or 1𝜇M
isoproterenol (both Sigma-Aldrich) was added to the buffer.
2.6. Statistical Analysis. Statistical analysis was performed
using the SigmaStat 4 software (Systat Software GmbH,
Erkrath, Germany). Comparison of groups was made using a
one-way analysis of variance (ANOVA) followed by a post hoc
Bonferroni test for multigroup comparisons or via Student’s
𝑡-test for single group comparisons (𝑝 < 0.05 considered
significant). Data is shown as mean ± standard error of the
mean (SEM) unless stated otherwise.
3. Results
3.1. Skeletal Muscle Preparation and Initial Cell Characteriza-
tion. The mechanical and enzymatic dissociation of skeletal
muscles isolated from neonatal mice resulted in 27.5 ± 1.4
× 106 per gram of tissue (𝑛 = 12). Three serial preplating
steps (pP1–pP3) reduced cell numbers, that is, numbers of
vital nonadherent cells, to 20.3 ± 1.9 × 106 after pP1, to
9.4 ± 1.2 × 106 after pP2, and to 7.9 ± 1.0 × 106 after pP3
(Figure 1). The resulting population of nonadherent, cluster-
forming cells after pP3 was termed ISH0, since it served
as the initial population (day 0) of cells, which was then
split and subjected to three different cell culture conditions:
static incubation (I), dynamic incubation on a horizontal
shaker (S), and preculture in hanging drops (H) with sub-
sequent culture on a shaker. ISH0 cells formed clusters of
spontaneously beating cells. Flow cytometric analyses (𝑛 =
5) revealed a heterogeneous cell population with a majority
of cells expressing the pan-muscle marker desmin (82.5% ±
4.4%) and substantial fractions of cells expressing cardiac
troponin T (cTnT, 35.6% ± 7.4%), stem cell lineage marker
Sca-1 (32.0% ± 3.7%), and skeletal muscle progenitor cell
specific transcription factor Pax7 (19.9% ± 10.4%). Addi-
tionally, smaller fractions of cells were also positive for the
hematopoietic stem cell marker CD34 (9.0% ± 0.8%) and
cardiac transcription factor Nkx2.5 (1.9% ± 0.1%).
3.2. Impact of Dynamic Support Culture on Cluster Morphol-
ogy and Cell Numbers. Sizes of cell clusters (Figures 2(a)
and 2(b)) after 12 days of static culture conditions did not
differ significantly from initial ISH0 cell clusters (ISH0: 66.4
± 2.0 𝜇m, 𝑛 = 9; I12: 68.2 ± 5.2𝜇m, 𝑛 = 5), but clusters
were significantly larger under both dynamic conditions (S12:
121.2 ± 3.9 𝜇m; H12: 114.7 ± 5.2𝜇m; both 𝑝 < 0.001 versus
ISH0 and I12). Development of the number of nonadherent
cells counted in suspension over the course of 12 days did
not differ significantly among I, S, and H and showed a loss
of approximately 6% of nonadherent cells per day, resulting
in 28.4% (I: 3.13 ± 2.36 × 106 cells), 19.4% (S: 2.14 ± 1.34 ×
106 cells), and 17.3% (H: 1.9 ± 1.53 × 106 cells) of the original
ISH0 cells remaining after 12 days (Figure 2(c)). Although
cell numbers continually declined during 12 days of static
or dynamic culture (Figure 2(c)) an increase in ratios of
nonadherent cells was observed (Figure 2(d)).
3.3. Impact of Dynamic Support Culture on Cardiac Marker
Expression. Clusters from ISH0 and after 12 days of culti-
vation under different conditions were analyzed immuno-
cytochemically for the expression of cardiac and myogenic
markers. Staining of intact clusters did not reveal marker
expression to be localized to specific regions of a cluster
(Figures S1 and S2). Thus, immunocytochemical analyses
were performed on single cells from dissociated clusters.
Specificity of antibody staining was confirmed with appro-
priate controls (Figure S3). Quantification of ratios of cells
expressing skeletal and cardiacmusclemarkers desmin, cTnT,
Pax7, and Nkx2.5 in ISH0 confirmed the results acquired by
flow cytometric analysis (Figures 3 and S4). Further analyses
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Figure 1: Isolation of MDSCs from neonatal murine skeletal muscles. (a) Total number of nonadherent cells (per g of muscle tissue) and
ratios of nonadherent cells (b) during three preplating steps (pP1–pP3). Panels (c–f) show representative images of nonadherent cells during
the preplating procedure: before plating (pP0, (c)), 2 hours (pP1, (d)), 26 hours (pP2, (e)), and 74 hours (pP3, (f)) after plating. Scale: 100 𝜇m.
(g) Flow cytometric assessment of cardiac and skeletal muscle specific markers for cells from ISH0 cell population (𝑛 = 5).
covered myogenic regulatory factors 3 and 4 (Myf3 and
Myf4), cardiac specific 𝛼-actinin 2 (ACTN2), and cardiac
specific transcription factor GATA4 and revealed ratios of
>35%Myf3 andMyf4 positive cells and>80%desmin positive
cells for ISH0 and all three culture conditions at day 12
(Figures 3 and S4–S7). The ratios of cells expressing Pax7
decreased significantly until day 12 for all culture conditions
except S12, while ratios of cells that expressed the cardiac
markers ACTN2, cTnT, and Nkx2.5 increased significantly
after ISH0 for all conditions. Compared to ISH0, the expres-
sion of GATA4was similar in I12 and S12 but was significantly
increased in H12 (Figures 3 and S4–S7).
The expression of connexin 43 (Cx43), 𝛼-myosin heavy
chain 6 (MYH6), cTnT, ACTN2, and Nkx2.5 were analyzed
by qPCR on the transcript level. Purified ESC derived CMs
and MBs were used as controls. Compared to CMs and MBs,
ISH0 showed an intermediate expression level for MYH6,
cTnT, andNkx2.5, while the expression level for Cx43 of ISH0
was similar to MBs (Figures 4 and S8). Comparing cells from
day 4 and day 12 of the three different culture conditions to
ISH0 cells, the expressions of MYH6 and cTnT were already
increased more than 5-fold in cells at day 4 (I4 and S4 versus
ISH0: 𝑝 < 0.05; H4 versus ISH0: 𝑝 < 0.001) and further
increased in I12 (13.6-fold; 𝑝 < 0.01 versus ISH0) and H12
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Figure 2: Characteristics of cell clusters derived from MDSCs. (a) Representative phase contrast microphotographs of cell clusters from
different cell culture conditions. While single contracting cells and smaller clusters were visible in ISH0 cultures, most cells were organized in
clusters of loosely attached cells applying static (I) and dynamic (S and H) culture conditions at day 12 of cultivation (I12, S12, and H12). Scale:
100𝜇m. (b) Average sizes of clusters in initial ISH0 cell populations and after twelve days applying different culture conditions. ∗∗∗𝑝 < 0.001.
(c) Total numbers of nonadherent cells obtained from muscles of 10 neonatal mice over the course of 12 days applying different culture
conditions (𝑛 = 12). (d) Ratios of nonadherent cells over the course of 12 days applying different culture conditions (𝑛 = 12).
cells (55.2-fold; 𝑝 < 0.001 versus ISH0).The expression levels
of cTnTweremore than 3-fold higher in cells at day 4 in all cell
culture conditions compared to ISH0 (I4 andH4 versus ISH0:
𝑝 < 0.01; S4 versus ISH0: 𝑝 < 0.05).The highest level of cTnT
expression was detected in H12 cells (17.5-fold; 𝑝 < 0.001
versus ISH0). During 12-day cultivation in all three culture
conditions, Cx43 and ACTN2 showed only minor changes
in expression levels, ranging from 0.5- to 2-fold (Figures 4
and S8). Nkx2.5 showed a tendency for increased expression,
especially for condition H (H4: 27x, H12: 182x), but without
reaching significance, presumably, because of very low overall
expression levels (1,000-fold less than endogenous control).
3.4. Functional Characteristics of MDSCs Cultured under
Dynamic Support In Vitro. The observation, that cells in
clusters of MDSCs cultured under dynamic support express
cardiac specific proteins and transcripts, prompted us to
closer explore their functional properties. For this reason
electrophysiological patch-clamp measurements were per-
formed on spontaneously beating single cells obtained from
ISH0 clusters and day 12 samples applying different condi-
tions. Spontaneous contractions of cells from ISH0 occurred
irregularly and frequently stopped after a seal was established.
Out of 51 cells that were patch-clamped, 3 cells (5.9%) could
be successfully analyzed, all of which exhibited irregular
6 Stem Cells International
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Figure 3: Immunocytochemical quantification of skeletal and cardiac muscle markers in MDSCs cultured under dynamic support. Cell
clusters from the initial cell population (ISH0) and after applying different cell culture conditions for 12 days (I12, S12, and H12) were
dissociated, plated, and stained for desmin, cTnT, Nkx2.5, Pax7, Myf3, Myf4, ACTN2, and Gata4. Ratios were calculated as positive cells
(stained for marker) versus total cells (stained for DAPI). ∗/∗∗/∗∗∗𝑝 < 0.05/0.01/0.001.
beating, characterized by short episodes of burst-like activity.
After 12 days of cultivation, spontaneous cell contractions
were more stable and regular in each culture condition: in
the I12 group, out of 77 analyzed, 8 (10.4%) cells showed
regular and 7 (9.1%) irregular beating activity and in the S12
group, 37 cells were patched and 8 (21.6%) showed regular
and 4 (10.8%) irregular beating, while in the H12 group, out
of 89 measured cells, 9 (10.1%) exhibited regular and 5 (5.6%)
cells irregular activity. Representative traces of irregularly and
regularly beating MDSCs are displayed in Figure S9.
The frequency of spontaneous action potentials (APs)
was similar in ISH0 (360.6 ± 81.6 beats/min) and H12 cells
(444.4 ± 39.3 beats/min), while cells from I12 and S12 showed
more than 2x higher frequencies (Table 1). Analysis of AP
parameters revealed that I12 cells showed a more depolarized
maximum diastolic potential (MDP), shorter AP duration
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Figure 4: Continued.
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Figure 4: Expression of cardiomyocyte-specific transcripts in MDSCs cultured under dynamic support. Skeletal myoblasts, purified
embryonic stem cell-derived cardiomyocytes, and cells from I, S, and H cell culture conditions on days 4 and 12 of cultivation were analyzed
by qPCR. Expression levels of indicated genes were normalized to the reference gene 𝛽-actin and displayed as relative expression compared
to ISH0 cells. Calculation of statistical significance was based on ΔCt values (see Figure S8). ∗/∗∗/∗∗∗𝑝 < 0.05/0.01/0.001.
Table 1: Action potential parameters of cell populations from different cell culture conditions.
Amplitude (mV) MDP (mV) APD (ms) BF (1/min) 𝑉max (V/s)
ISH0 32.1 ± 5.7§ −59.6 ± 2.6 234.6 ± 24.9 360.6 ± 81.6 22.6 ± 3.1§§
I12 38.3 ± 5.8## −34.2 ± 3.9 85.5 ± 6.8∗ 821.5 ± 92.8∗∗∗ 11.6 ± 1.2+
S12 33.1 ± 4.7# −44.1 ± 3.9 106.4 ± 16.2 777.5 ± 73.3∗∗ 17.1 ± 0.7
H12 27.2 ± 2.6 −44.4 ± 3.5 172.7 ± 22.9 444.4 ± 39.3§§ 15.9 ± 1.7
BF: beating frequency; MDP: maximum diastolic potential; APD: action potential duration; 𝑉max: maximum upstroke velocity.
∗/∗∗/∗∗∗
𝑝 < 0.05/0.01/0.001
(vs. ISH0); §/§§/§§§𝑝 < 0.05/0.01/0.001 (vs. I12); +/++/+++𝑝 < 0.05/0.01/0.001 (vs. S12); #/##/###𝑝 < 0.05/0.01/0.001 (vs. H12).
(APD), and lower maximum AP upstroke velocity (𝑉max)
than ISH0, S12, and H12 cells (Figure 5(b)). However, the
morphology of APs from cells cultured under different
conditionswas similar, characterized by a slowdepolarization
before each AP, fast upstroke, and short AP duration, without
a plateau phase after the AP upstroke (Figure 5(a)). Further,
APs (Figure 5(b), left panel) and 𝐼
𝑓
currents (Figure 5(b),
right panel) were recorded from the same cell by switching
from current-clamping to voltage-clamping as previously
described [27]. We examined the functional expression of
𝐼
𝑓
in spontaneous beating cells generated under ISH10, I12,
S12, and H12. The typical representative 𝐼
𝑓
current traces
(Figure 5(b), right) recorded on nonbeating (upper) and
beating (lower) ISH10 cells are depicted. Several beating cells
revealed the presence of 𝐼
𝑓
current whereas most of the
nonbeating cells were characterized by the absence of 𝐼
𝑓
current, confirming the important role of 𝐼
𝑓
in the generation
and modulation of spontaneous beating activity of the cells.
We further determined whether ISH0, I12, S12, and
H12 cells responded to cardiac channel specific chemical or
pharmacological stimuli (representative traces are displayed
in Figure S9). Application of 0.5mMCdCl
2
, which selectively
blocks cardiac AP generation, but has no effect on skeletal
myotubes [21], abolished spontaneous beating of cells in all
groups (ISH0: 𝑛 = 1, I12: 𝑛 = 5, S12: 𝑛 = 2, H12: 𝑛 =
4). Exposing the cells to 𝛽1-adrenergic agonist isoproterenol
(1 𝜇M) increased the AP frequencies in cells from all culture
conditions (ISH0: 𝑛 = 1, I12: 𝑛 = 1, S12: 𝑛 = 2, H12: 𝑛 = 2).
Both effects were reversible by washout.
4. Discussion
In this study, we sought to investigate whether cells isolated
from skeletal muscle can be altered in a nontransgenic way
to acquire CM-like properties, eventually allowing functional
integration into damaged myocardium to improve heart
function. In order to achieve the transition of skeletalmuscle-
derived cells to CM-like cells various approaches have been
followed. Since skeletal muscle cells generally have a contrac-
tile and electrically excitable phenotype, changes required for
adoption of a cardiac phenotype might be less drastic than,
for example, transgenic conversion of fibroblasts to CMs [28].
The isolation of neonatal skeletal muscle cells with CM-like
features or cardiogenic potential has been described before
[21], but information regarding the influence of specific
culture conditions is rare. The choice of neonatal skeletal
muscle tissue as a source of potentially cardiogenic cell
population has been shown to be instrumental, since adult
skeletal muscle tissue yields only marginal amounts of cells
viable in cell culture.
The initial nonadherent cell population (ISH0) obtained
after skeletal muscle dissociation and preplating was phe-
notypically heterogeneous, as shown by flow cytometric
analysis.The great majority of cells expressed the pan-muscle
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Figure 5: Electrophysiological analyses of MDSC-derived cells. (a) Representative action potential traces of initial cell population (ISH0)
and after applying different cell culture conditions for 12 days (I12, S12, and H12) as measured by a whole-cell patch-clamp in current-clamp
mode. (b) Voltage clamp measurements for recording of the pacemaker current 𝐼
𝑓
. The applied voltage protocol is shown above the traces,
which are representative for cells which do not express (upper trace) and which express small (lower trace) 𝐼
𝑓
currents.
marker desmin and about 30% were positive for stem cell
marker Sca-1, indicative of MDSCs [20]. The cardiac struc-
tural protein cTnT was expressed at similar levels, suggesting
cardiogenic potential already in the initial cell population
ISH0.
Methods that support clustering of cells, like the hanging
drop technique [29] and mass suspension cultures [30], have
been described to increase cardiac lineage differentiation of
pluripotent stem cells and the generation of cardiospheres
[31]. We sought to explore if these culture methods could
increase the cardiogenic potential ofMDSCs and if acceptable
cell numbers for subsequent analyses and applications could
be generated. As expected, after 12 days of cell culture,
clusters obtained applying dynamic conditions (S and H)
were significantly larger than those found in conventional
static conditions (I), while the total number of cells in
clusters remained similar in all three conditions. However,
a continuous loss of cells was observed and only about 22%
of the initial ISH0 cell population remained after 12 days. A
growth lagwas described previously forMDSCs and is as such
not a surprise [32]. Apparently, however, dynamic culture
does not promote cell proliferation over standard incubator
culture. Thus, in light of necessary expansion of cells to
achieve clinically relevant cell numbers, culture conditions
need to be further optimized, for example, by supplementing
appropriate growth factors, small molecules, or extracellular
matrix components to counter the observed loss of cells or
improve proliferation [33].
Analyses of cardiac specific markers confirmed that cells
with CM-like expression patterns were already present in
the initial ISH0 cell population and showed that these cells
could be enriched after 12 days of expansion, applying cluster
promoting conditions, as reflected by significantly increased
ratios of cells expressing cardiac markers ACTN2, cTnT,
and Nkx2.5. Remarkably, expression levels of skeletal muscle
markers Myf3 andMyf4 remained constant for all conditions
applied. This finding is consistent with a recent report,
demonstrating that the expression of these markers is inde-
pendent of cluster size and that their sustained expression
does not influence the cells cardiogenic potential in vivo
[34], with the general presence of skeletal muscle markers
during MDSC isolation [32]. It is important to note that the
expression of Pax7 was defined as indicating the presence
of skeletal muscle progenitor cells and was not understood
as a marker of skeletal myogenic potential but primarily as
a reflection of the populations stemness and proliferation
potential [35], which apparently remains present to some
degree during dynamic support and is in agreement with
cluster size correlations in clonal studies [36].
qPCR analyses revealed that cardiac markers were
expressed significantly lower in ISH0 cells compared to ESC
derived CMs, which were understood as a prototypical stem
cell population of high cardiogenic potential in this setup,
but were significantly higher expressed than in MBs, which
were used as the baseline control for cardiogenic potential
of skeletal muscle cells. Comparing the expression levels
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between the initial ISH0 cells and after 12 days of cell
culture revealed that the expression of cardiac structural
proteins Myh6 and cTnT was significantly increased in all
three conditions. Interestingly, cells from dynamic culture
conditions (S and H) showed the highest expression levels,
although not reaching the expression levels of ESC derived
CMs. This suggests that full transition of MDSCs to a CM-
like phenotype in vitro requires further optimization. The
fact that the expression of late cardiac structural (Myh6
and cTnT) and functional markers (Cx43) is comparable to
levels in ESC derived CMs is in our eyes more relevant than
the expression of basic sarcomeric structural markers like
ACTN2 or early markers of cardiac determination (Nkx2.5)
and makes a point for the principal maturation of the cells
towards a cardiac phenotype, which is most pronounced
under dynamic culture conditions. This increase of cardiac
marker expression in dynamic culture was consistent with
a previous report in which the higher cell content in clonal
clusters was positively correlated with increased cardiac
marker expression and cardiac differentiation potential [34].
While, given the difference in source tissue, unsurpris-
ingly not every cardiac marker shows the same relative
expression levels in MDSCs cultured under dynamic support
as compared to the dedicated high cardiogenic potential
population of ESC derived CMs, our analyses make clear that
dynamic support culture of MDSCs incrementally narrows
the deterministic gap between these cell populations towards
a cardiac-like development.
SinceMDSCs showed spontaneous beating activitywhich
was shown to be linked to the cardiac specific 𝐼
𝑓
current
[37] and expressed CM-specific markers, especially in cells
obtained in dynamic cultures, we analyzed the electrophys-
iological properties of these cells by whole-cell patch-clamp
measurements. Action potentials could be recorded from
cells of all conditions, documenting their general electro-
physiological competence.The beating frequencies measured
(440 to 820 beats/min at day 12) were much higher compared
to murine ESC and induced pluripotent stem cell derived
CMs, which range between 70 and 160 beats/min [26], thus
being more similar to the physiological beating frequency
of adult mouse hearts, which reportedly ranges between
450 and 800 beats/min [38]. During 12 days of culture the
resting potential and spontaneous beating frequencies of cells
cultured applying all conditions increased, while their AP
duration decreased, which is consistent with observations of
murine pluripotent stem cells differentiating to CMs [26].
Morphological analyses of APs measured in cells of each
condition were, however, different frommature adult murine
ventricular CM APs [39] and murine ESC derived atrial-
like CMs and ventricular-like CM APs [26]. The overall AP
morphology was reminiscent of pacemaker cells, which are
characterized by a lower MDP and amplitude and a higher
frequency than atrial and ventricular APs [40, 41].
It has been shown before that MDSCs react to external
chemical stimulation in a manner similar to CMs, char-
acterized by a reversible increase in beating frequency in
response to isoproterenol and a reversible decrease in beating
frequency in response to CdCl
2
, while skeletal muscle cells
andmyotubes were not affected [21]. In our hands, thesemea-
surements proved to be technically challenging, but cells from
all indicated populations, including ISH0, when successfully
measured, showed reversible CM-like responses to these
substances, indicating CM-like phenotype and functionality,
confirming the aforementioned study’s findings.
All results considered that cells from the H12 population
displayed the most promising combined features of a conver-
sion from a skeletal towards a cardiac phenotype in vitro. The
correlation between the increased cardiogenic potential and
the dynamic support these cells were exposed to is the core
finding of our presented study.
5. Conclusion
We showed that enforced and sustained nonadherence and
cluster formation through dynamic culture and additionally
hanging drop pretreatment ofMDSCs significantly improved
their transition towards a CM-like phenotype. In the future,
it will be exciting to tailor the dynamic support culture
protocols towards the enrichment of a ventricular CM-like
phenotype and assess engraftment and potential therapeutic
effects using in vivo disease models.
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